Blood pressure drug increases heart failure survival, study shows
Blood pressure drug aliskiren can delay the progression of congestive heart failure and extend survival rates, a preclinical study has found.
Blood pressure drug aliskiren can delay the progression of congestive heart failure and extend survival rates, a preclinical study has found.
Extreme heat is tied to a high risk of same-day hospital admission and death in people with end-stage renal disease, a new study has found.
High doses of the diuretic spironolactone may resolve fluid overload in heart failure patients who don’t respond to standard treatment.
As healthcare workers, especially as healthcare workers in long-term care, we don’t have jobs that most people can identify with.
Economic incentives – both good and bad – are a proven way to modify behavior. But what happens when an economic penalty is based on a dubious premise? Many hospitals may soon be forced to answer that question. And many skilled care operators may have to live with some very unwelcome fallout.
Individuals suffering from both heart failure and depression could see improvement with the introduction of an exercise program, a new study reveals.
Texas has received a windfall of federal funding to test care coordination programs between acute and long-term care providers.
More focused treatment of common illnesses among dually eligible Medicare and Medicaid beneficiaries could cut costs and lower hospital readmissions, researchers found.
An overnight breathing treatment called adaptive servo-ventilation (ASV) therapy was shown to be helpful in individuals with chronic heart failure, new research suggests.
The Department of Health and Human Services has announced its newest round of grant recipients under its Health Care Innovation Awards.